Video

Journal of Clinical Pathways spoke with Andrew Hertler, MD, about the role of genomics influencing clinical pathways in the near future (September 8-10, 2017; Washington, DC).
Journal of Clinical Pathways spoke with Andrew York, PharmD, a CMS pharmacist, regarding the payer’s role—specifically, the Oncology Care Model’s role—in the transition towards value-based care (September 8-10, 2017; Washington, DC).
Journal of Clinical Pathways spoke with Robert Daly, MD, MBA, regarding the role of evidence in designing clinical pathways and the future of pathways in health care (September 8-10, 2017; Washington, DC).
Journal of Clinical Pathways spoke with James Mohler, MD, about the relationship between clinical pathways and the current treatment landscape for prostate cancer (September 8-10, 2017; Washington, DC).
Journal of Clinical Pathways spoke with Robin Zon, MD, FACP, FASCO​​​​​​​, about her role with the ASCO Task Force and her presentation at the Clinical Pathways Congress, "ASCO'S Policy on Clinical Pathways - Future Direction" (September 8-10, 2017; Washington, DC).
Journal of Clinical Pathways spoke with Bruce Feinberg, DO, about the process of developing clinical pathways and his experience moderating the Breast Cancer Clinical Pathway Committee Development Meeting (September 8-10, 2017; Washington, DC).

Reducing agitation in patients with Alzheimer's disease.